While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
Pharma giant targets new standards of care
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
At launch of updated pediatric gastroenterology textbook, Union Minister says technology must strengthen not substitute core medical learning
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The acquisition adds VYKAT XR (diazoxide choline), the first FDA-approved therapy for hyperphagia in Prader-Willi syndrome (PWS), a rare genetic disorder, to Neurocrine’s portfolio
Subscribe To Our Newsletter & Stay Updated
